A Study to Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer
Clinical trial NCT03548467 · COMPLETED
Trial details
- NCT number
- NCT03548467
- Sponsor
- Nykode Therapeutics ASA
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-04
- Primary completion
- 2023-01-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.